COVID-19 Project Team: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 13: | Line 13: | ||
'''Cardiovascular Disorders of COVID-19 Team Members''' | '''Cardiovascular Disorders of COVID-19 Team Members''' | ||
*Alieh Bahjat | *[[User:Behjat|Alieh Bahjat]] | ||
*'''[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]]''' | *'''[[User:Mandana Chitsazan|Mandana Chitsazan, M.D.]]''' | ||
*'''[[User:Mitra Chitsazan|Mitra Chitsazan]]''' | *'''[[User:Mitra Chitsazan|Mitra Chitsazan]]''' | ||
| Line 19: | Line 19: | ||
*[[User:Mounika|Mounika Vadiyala]] | *[[User:Mounika|Mounika Vadiyala]] | ||
*Sara Haddadi | *Sara Haddadi | ||
*Sara Zand | *[[User:Sara Zand|Sara Zand]] | ||
*Syed Rizvi | *[[User:Syed rizvi|Syed Rizvi]] | ||
*[[Tayyaba Ali, MD|Tayyaba Ali, M.D.]] | *[[Tayyaba Ali, MD|Tayyaba Ali, M.D.]] | ||
| Line 26: | Line 26: | ||
*'''[[User:Aditya Ganti|Aditya Ganti, M.B.B.S.]]''' | *'''[[User:Aditya Ganti|Aditya Ganti, M.B.B.S.]]''' | ||
*[[user:Nuha|Nuha AL-Howthi, MD]] | *[[user:Nuha|Nuha AL-Howthi, MD]] | ||
*[[Ogechukwu Hannah Nnabude, MD]] | *[[User:Nnabude|Ogechukwu Hannah Nnabude, MD]] | ||
'''Frequently Asked Inpatient Questions Team Members''' | '''Frequently Asked Inpatient Questions Team Members''' | ||
| Line 45: | Line 45: | ||
'''Gastrointestinal disorders and of COVID-19''' | '''Gastrointestinal disorders and of COVID-19''' | ||
*'''Farima Kahe''' | *'''[[User:Farima Kahe|Farima Kahe, M.D.]]''' | ||
*[[Tayyaba Ali, MD|Tayyaba Ali, M.D.]] | *[[Tayyaba Ali, MD|Tayyaba Ali, M.D.]] | ||
| Line 51: | Line 51: | ||
*'''[[User:Ramyar Ghandriz|Ramyar Ghandriz, M.D.]]''' | *'''[[User:Ramyar Ghandriz|Ramyar Ghandriz, M.D.]]''' | ||
* [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]] | * [[User:Ifrah Fatima|Ifrah Fatima, M.B.B.S]] | ||
*Shakiba Hassanzadeh | *[[User:ShakibaHassanzadeh|Shakiba Hassanzadeh]] | ||
*Fausat Adogba | *Fausat Adogba | ||
| Line 77: | Line 77: | ||
*'''[[User:Sara Mohsin|Sara Mohsin, M.B.B.S.]]''' | *'''[[User:Sara Mohsin|Sara Mohsin, M.B.B.S.]]''' | ||
* Ayesha Farheen Javid | * Ayesha Farheen Javid | ||
* Usman Ali | * [[User:Usmanaliakbar|Usman Ali Akbar]] | ||
*Rina Ghorpade | *[[User:Rina Ghorpade|Rina Ghorpade]] | ||
*Rana Aljebzi (not trained yet) | *Rana Aljebzi (not trained yet) | ||
Revision as of 16:39, 17 June 2020
| COVID-19 Project |
|---|
| Introduction |
| Team |
| Meetings' Summary |
| Topics |
| Ongoing Clinical Trials |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Meet The Team
Associate Editor(s)-in-Chief:
- The name of the leaders are written in bold:
Cardiovascular Disorders of COVID-19 Team Members
- Alieh Bahjat
- Mandana Chitsazan, M.D.
- Mitra Chitsazan
- Mandana Safakhah
- Mounika Vadiyala
- Sara Haddadi
- Sara Zand
- Syed Rizvi
- Tayyaba Ali, M.D.
Dermatologic Disorders of COVID-19 Team Members
Frequently Asked Inpatient Questions Team Members
- Gurmandeep Singh Sandhu, M.B.B.S.
- Aisha Adigun, M.D.
- Harmeet Kharoud, M.D,. MPH
- Rinky Agnes Botleroo, M.B.B.S.
- Nuha AL-Howthi, MD
- Ifrah Fatima, M.B.B.S
- Ogechukwu Hannah Nnabude, MD
Frequently Asked Outpatient Questions Team Members
- Roukoz Abou Karam, M.D.
- Aisha Adigun, M.D.
- Bosky Soni, M.D., MPH
- Neepa Shah, M.D
- Indhumathi Venkatasubramani balaraman, M.D.
Gastrointestinal disorders and of COVID-19
Hematologic disorders of COVID-19 Team Members
- Ramyar Ghandriz, M.D.
- Ifrah Fatima, M.B.B.S
- Shakiba Hassanzadeh
- Fausat Adogba
Nephrologic Disorders of COVID-19 Team Members
- Sogand Goudarzi, M.D.
- Gurmandeep Singh Sandhu, M.B.B.S.
- Nasrin Nikravangolsefid, M.D, MPH
- Mydah Sajid, M.D.
Neurologic Disorders and COVID-19 Team Members
- Fahimeh Alsadat Shojaei, M.D.
- Syed Musadiq Ali, M.D.
- Niloofarsadaat Eshagh Hosseiny, M.D.
- Muhammad Adnan Haider
- Rinky Agnes Botleroo, M.B.B.S.
Ongoing Clinical Trials of COVID-19 Team Members
Pediatrics and COVID-19
Pulmonary Disorders and COVID-19 Team Members
- Sara Mohsin, M.B.B.S.
- Ayesha Farheen Javid
- Usman Ali Akbar
- Rina Ghorpade
- Rana Aljebzi (not trained yet)